295 related articles for article (PubMed ID: 28271680)
1. Tumor Abnormal Protein as a Novel Biomarker in Papillary Thyroid Carcinoma.
Liu Z; Cai J; Yu Y; Fang H; Si Y; Jankee JJ; Shen M
Clin Lab; 2017 Mar; 63(3):479-485. PubMed ID: 28271680
[TBL] [Abstract][Full Text] [Related]
2. Tumor Abnormal Protein in the Diagnosis of Breast Cancer in Patients with a Palpable Mass.
Chen WX; Yang LG; Cheng L; Zhu YL
Ann Clin Lab Sci; 2019 May; 49(3):297-301. PubMed ID: 31308027
[TBL] [Abstract][Full Text] [Related]
3. [The difference expression and diagnostic value of RPL5 in papillary thyroid carcinoma of children and adults].
Jin YQ; Wang SC; Tai J; Zhang J; Chen F; Shi J; Yu YB; Yang YR; Ren HM; Geng D; Liu YH; Guo YL; Ni X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):830-834. PubMed ID: 29141292
[No Abstract] [Full Text] [Related]
4. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
Yu S; Liu Y; Wang J; Guo Z; Zhang Q; Yu F; Zhang Y; Huang K; Li Y; Song E; Zheng XL; Xiao H
J Clin Endocrinol Metab; 2012 Jun; 97(6):2084-92. PubMed ID: 22472564
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?
Tang J; Gui C; Qiu S; Wang M
World J Surg Oncol; 2018 May; 16(1):100. PubMed ID: 29855303
[TBL] [Abstract][Full Text] [Related]
6. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of Serum lncRNA HOTAIR Combined with Galectin-3 in Benign and Papillary Thyroid Carcinoma.
Li L; Wang J; Li Z; Qiu S; Cao J; Zhao Y; Huang Z; He J; Luo F; Yang K
Cancer Manag Res; 2021; 13():6517-6525. PubMed ID: 34447269
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis.
Zhang Y; Meng Z; Zhang M; Tan J; Tian W; He X; Fu Q; Xu K; He Q; Zhu M; Li X; Zhang G; He Y; Jia Q; Zhang J; Wang S; Song X
Life Sci; 2014 Nov; 118(1):39-45. PubMed ID: 25283079
[TBL] [Abstract][Full Text] [Related]
9. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.
Brown LM; Helmke SM; Hunsucker SW; Netea-Maier RT; Chiang SA; Heinz DE; Shroyer KR; Duncan MW; Haugen BR
Mol Carcinog; 2006 Aug; 45(8):613-26. PubMed ID: 16788983
[TBL] [Abstract][Full Text] [Related]
10. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
[TBL] [Abstract][Full Text] [Related]
11. Differential expression levels of plasma-derived miR-146b and miR-155 in papillary thyroid cancer.
Lee YS; Lim YS; Lee JC; Wang SG; Park HY; Kim SY; Lee BJ
Oral Oncol; 2015 Jan; 51(1):77-83. PubMed ID: 25456009
[TBL] [Abstract][Full Text] [Related]
12. Serum level of interleukin-17 and interleukin-35 as a biomarker for diagnosis of thyroid cancer.
Lu Y; Yuan Y
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C209-11. PubMed ID: 26506878
[TBL] [Abstract][Full Text] [Related]
13. Image Risk Assessment of the Thyroid Cancer Model Based on Discriminant Analysis and the Value of TAP and CEA Combined Detection.
Wang B; Wang S; Lang S; Liang L; Yang Y; Xue Y; Xu Y
J Healthc Eng; 2021; 2021():8836288. PubMed ID: 34422249
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors for central neck lymph node metastases of papillary thyroid carcinoma].
Sun YS; Lyu HJ; Zhao YR; Zhang SS; Bai YX; Shi BY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):421-425. PubMed ID: 28635213
[No Abstract] [Full Text] [Related]
15. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.
Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X
J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217
[TBL] [Abstract][Full Text] [Related]
16. Metabolite analysis-aided diagnosis of papillary thyroid cancer.
Chen J; Hu Q; Hou H; Wang S; Zhang Y; Luo Y; Chen H; Deng H; Zhu H; Zhang L; Liu H; Wang A; Liu Y
Endocr Relat Cancer; 2019 Dec; 26(12):829-841. PubMed ID: 31671400
[TBL] [Abstract][Full Text] [Related]
17. ProNGF is a potential diagnostic biomarker for thyroid cancer.
Faulkner S; Roselli S; Demont Y; Pundavela J; Choquet G; Leissner P; Oldmeadow C; Attia J; Walker MM; Hondermarck H
Oncotarget; 2016 May; 7(19):28488-97. PubMed ID: 27074571
[TBL] [Abstract][Full Text] [Related]
18. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
[TBL] [Abstract][Full Text] [Related]
19. TAP Test Image Dynamic Tracking Study after Thyroid Cancer Surgery and after Radiotherapy and Chemotherapy.
Wang C; Gu Y; Men X; Sun P; Chen M
Comput Math Methods Med; 2021; 2021():8072126. PubMed ID: 33953794
[TBL] [Abstract][Full Text] [Related]
20. Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma.
Lai CW; Chen KY; Hung CS; Kuo SW; Chang YJ; Lin MT; Chang KC; Wu MH
Growth Factors; 2011 Apr; 29(2-3):57-62. PubMed ID: 21319951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
